SSB published a research report on 19 Feb wherein they value ALL at $3.75 on a DCF basis and $2.41 on an EV/EBITDA basis.
They also say the stock is high risk.
SSB analyst Jenny Owen was also reported in todays AFR as saying "The company presentation (on 17 Feb) only served to highlight the weakness evident in the 2002 result".
My own feeling is that ALL is a good buy at present levels and that once all the hysteria re alleged management failures and remuneration packages fades into the background we are likely to see $2.40 plus as advised by SSB.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$68.85 |
Change
0.170(0.25%) |
Mkt cap ! $42.65B | |||
| Open | High | Low | Value | Volume |
| $68.60 | $68.85 | $68.04 | $61.37M | 893.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 147 | $68.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $68.86 | 40 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2025 (20 minute delay) ? |
| ALL (ASX) Chart |